Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PEN - Penumbra Inc


Close
240.71
0.615   0.255%

Share volume: 7,390
Last Updated: Thu 26 Dec 2024 08:30:04 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%

$240.10
0.62
0.26%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
19%
Profitability 16%
Dept financing 26%
Liquidity 58%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
-0.08%
1 Month
-3.45%
3 Months
25.43%
6 Months
37.49%
1 Year
-7.60%
2 Year
9.52%
Key data
Stock price
$240.71
P/E Ratio 
552.12
DAY RANGE
$238.15 - $241.28
EPS 
$0.36
52 WEEK RANGE
$170.13 - $277.34
52 WEEK CHANGE
-$5.91
MARKET CAP 
7.859 B
YIELD 
N/A
SHARES OUTSTANDING 
38.844 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
0.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$403,239
AVERAGE 30 VOLUME 
$319,183
Company detail
CEO: Adam Elsesser
Region: US
Website: penumbrainc.com
Employees: 3,900
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand.

Recent news